Silence Therapeutics plc Retained Earnings
Silence Therapeutics plc (SLN) had Retained Earnings of -$589.63 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-10
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$589.63M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$577.53M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$562.57M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$550.80M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$589.63M 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$577.53M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$562.57M 10-Q · filed 2026-08-10 |
| 2025-09-30 | -$550.80M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$529.84M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$502.54M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$474.04M 10-K · filed 2026-03-05 |
| 2023-12-31 | -$431.89M 10-K · filed 2025-02-27 |